Minimal residual disease (MRD), also known as molecular residual disease, or measurable residual disease, is the medical condition in which small number of cancer cells persist in a patient either during or after treatment when the patient is in remission and that cannot be detected with current medical imaging or routine screening options ...

NGS tabanlı MRD klonalite testi, hassas ve objektif olması, standartlaştırılması kolay olması ve aynı anda birden fazla klonotipi izlemek için kullanılabilmesi nedeniyle alternatif yöntemlere göre önemli avantajlar sunar.

e-Devlet Kapısı'nı kullanarak kamu kurumlarının sunduğu hizmetlere tek noktadan, hızlı ve güvenli bir şekilde ulaşabilirsiniz.

Türk Manyetik Rezonans Derneği, 29 Aralık 1994 tarihinde İzmir’ de ülkemizde Manyetik Rezonans ile ilgili çalışmaları geliştirmek amacı ile Manyetik Rezonans Derneği adı altında kurulmuştur. 2005 yılında adı Türk Manyetik Rezonans Derneği olarak değiştirilmiştir.

The European LeukemiaNet AML MRD Working Party (ELN-DAVID), a global consortium of experts meeting quarterly, plays a pivotal role in reviewing new data, advancing standardization projects, and achieving consensus on MRD procedures and interpretation.

MRD testing detects tiny amounts of cancer left after treatment, helping doctors decide if more therapy is needed or if it’s safe to stop.

Minimal residual disease (MRD) is common in patients with blood cancers, such as leukemia, lymphoma and multiple myeloma. But what does this mean for patients and their need for additional cancer treatment? Ghayas Issa, M.D., explains.

Liquid biopsy-mediated detection of minimal residual disease (MRD) allows monitoring of tumor activity at the molecular level before clinical and radiologic progression.

Download the Mr D app to enjoy convenient grocery and food delivery from over 11,000 restaurants and stores, and 300+ Pick n Pay grocery stores. Pay with cash, card, or EFT and get your order delivered to over 2,600 suburbs across South Africa. Satisfy your cravings with ease!

Minimal Residual Disease (MRD), also called measurable residual disease, refers to the small population of malignant cells that remain after treatment and are undetectable by conventional microscopy.